chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PT WAS INADVERTENTLY GIVEN A SHINGRIX VACCINE.  THIS VACCINE IS INDICATED IN PATIENTS 50 + PT DID NOT SUFFER ANY ILL EFFECTS FROM THIS VACCINE
swelling  and pain  around where the the short is given on the following  day which is Tuesday  then swelling  and pain on  my armpit  no the same left arm the following day which is Thursday morning
A day after the vaccine pt developed flue like symptoms, severe chills, headache, muscle ache, runny nose, nasal congestion.  On 3/17/21 pt developed a hive on the right cheek, then on 3/19/21 pt developed  hives all over body, went to hospital, was seen in ED sent home, hives continued beame so itchy all over her body, pt went back to hosp, admitted on 3/21/21, discharged on 3/22/21. Pt was given Prednisone. Pt took Benadryl at home which did not help.
Behaving differently like paranoid; This is a spontaneous report from a contactable consumer. A 83-year-old female patient received first  dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 22Jan2021 as a single dose for COVID-19 immunization. The patient's medical history included macular degeneration that are shots in the eye. The patient's concomitant medication included saffron. On the same day of vaccination after a while, the patient started behaving differently like paranoid that her daughter and grandson where stealing from her, out of the blue and the patient had not been behaving like that before. The patient got the second dose on 12Feb2021. The patient got the physician performed CT scan and blood work, but they came good. The patient wanted to know if that was something that has been reported. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
The day after the injection she noticed multiple swollen lymph nodes, 2 in her axilla, 1 near her clavicle and one near her throat.
Mother reported that when her daughter came home from school (where she recieved her 2nd H1N1 vaccine) she noticed her scratching and when she removed her shirt she had hives, rash, and swelling.  Her eyes were starting to swell.
sz & eye blinking, twitching & loss of consciousness for several minutes;treated w/IV solumedrol;dx sz disorder, encephalitis; still being treated. Annual follow-up dated 02/21/01 states the pt has a developmental delay and seizure disorder.
Patient received wrong vaccine (under 5year). No reaction, explained to the parents what is a next step.
My arm pit became very sore and my arm would go numb every time I was sleeping. This occurred for around 10 days. My arm was very sore with about 3 inch round rash around the injection site. The 3? rash was a hard ball.
This case was reported by a healthcare professional and described the occurrence of decreased therapeutic response in an adult subject of unspecified gender who was vaccinated with TWINRIX adult (GlaxoSmithKline). On an unspecified date in 2012 the subject received 1st or booster dose of TWINRIX adult (unknown, unknown arm). At an unspecified time within two months of vaccination with TWINRIX adult, the subject experienced decreased therapeutic response. Subject had a viral syndrome either flu or cold (upper respiratory infection) at the time of vaccination and was receiving the TWINRIX for travel and experienced not having the appropriate titer response.
Pt recvd 3 Hep B vax given 1AUG89, 31AUG89, & 29JAN90; following these, titer was neg; Pt was given a 4th dose of Engerix-B vax on 15AUG90; Following 4th dose titer was neg;
About two days after getting the Arexvy Vaccine, patient came to the pharmacy and reported redness and inflammation at  the vaccine injection site.
Pt received vaccine on 7/18/12 & came in on 7/21/12 with redness around the injection site measuring about 2" x 3". Pt stated the area was warm & itched w/o pain. Told pt to take diphenhydramine. Apply abx oint & use ice if necessary. If rxn remained unchanged or worsened pt was advised to go to urgent care. Inj. site was unchanged from 7/20-7/21. Called pt 7/23/12 to follow up & she said her arm is getting better. She had been using ice packs.
About 8 varicella lesions on trunk and extremities with 3 days of predominant symptoms. Still with lesions.
Patient received vaccine and reported a feeling of chest discomfort, dizziness, and shakiness.  BP 138/84  HR 101 O2 sat 100%.  11:25 am BP 137/77   HR 105 O2 Sat 100.  Patient continues to report chest discomfort.  11:34 Given Allegra. 60 mg PO.  11:39 152/77 HR 108 O2 Sat 100% Patient states that she still has numbness in her mouth and jaw.  Her chest discomfort is better.  She is requesting to be evaluated at the ER.  Squad was called.  11:43 Squad arrived and patient taken to hospital.
12/20/13 - rec'd VARIVAX. 1/2/14 - fatigue. 1/3/14 - joint pain. 1/4/14 - vaccine site red. 1/5 - chicken pox spots. 1/13/14 - resolved.
Patient in office to see Dr. for Diabetes 3 mo. visit. Was given a PREVNAR 13 approximately at 10:30 and left office. Patient returned to office at 13:55 with complaints of chest pain, nausea, shortness of breath, sent to Hospital ER. Patient did have a Myocardial Infarction Bilateral Pulmonary Embolisms.
Immediate swelling left deltoid then redness. BENADRYL 50mg IM given - redness and swelling resolved 15 minutes. Monitored additional 30 minutes with no reaction. Driver provided by family.
felt like someone was sitting on her chest; the patient developed chills; stated she 'felt like someone was sitting on her chest' (PT Chest pain); This is a spontaneous report from a non-contactable pharmacist. A 32-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported, Age group: Adult 18-64 Years), dose 2 via an unspecified route of administration on Jan2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on Jan2021 as dose 1, single for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Jan2021 the patient experienced Several hours after the 2nd dose of the covid-19 vaccine, felt like someone was sitting on her chest, the patient developed chills, stated she 'felt like someone was sitting on her chest' (PT: chest pain). The patient took acetaminophen for treatment. The events resolved by the next morning. The outcome of event was recovered on Jan2021.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
My son had a low fever the day after his flu vaccine, but that evening it rose as high as 103.8 degrees.  He had chills and complained of a sore throat.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 16-FEB-2015, the patient was vaccinated with an improperly stored dose of (23-valent) PNEUMOVAX 0.5 mL (VIs 10 SDV) (Lot # K007822, expiration date 15-AUG-2015), dose, route and anatomical location were not provided. There was no concomitant medication provided. On an unknown dates, the (23-valent) PNEUMOVAX had a temperature excursion for 24, 96, 48, 24 and 2220 hours, with the lowest recorded temperature was 28F (-2.2 Celsius) and 40 hours with the highest recorded temperature 47.5 F (8.6 Celsius), 47.2 F (8.4 Celsius), 46.8 F (8.2 Celsius), 46.6 F (8.1 Celsius) and 59.9 F (15.5 Celsius) respectively. The vaccine status was reported as "in excursion", and was storage in a Refrigerator (R). There was no product quality complaint involved and no adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.
Never had the flu. Took the shot once. Almost wound up in the hospital. Never again.; Initial information was received on 11-Oct-2020 regarding an unsolicited valid serious case from a consumer or non-healthcare professional.  This case involves an adult patient who almost wound up in the hospital(hospitalization), after the patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via an intramuscular route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient almost wound up in the hospital (hospitalization) (unknown latency) following the administration of INFLUENZA VACCINE..  Details of laboratory data were not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the event outcome was unknown.  Information on the batch number is requested.; Sender's Comments: This case involves an adult patient who experienced wound (unknown latency) after vaccination with INFLUENZA VACCINE produced by unknown manufacturer. The time to onset is unknown. Further information regarding concurrent condition during vaccination, previous vaccination and tolerance, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
On the evening of having the vaccine I was getting ready to take a shower and noticed raised reddish/ pink splotches on my neck and chest. The next morning my body was becoming itchy and gives were appearing on my arms, stomach, back, legs, etc. Over the course of a few days my entire body was covered in hives and I was having difficulties breathing. By the time I saw my primary care doctor I was extremely uncomfortable, persistent itchiness. I was given various meds however, they were not very effective. Eventually I was Sent to a dermatologist where an exam and biopsy was done on one of the largest hives. The results as I was told was due to a drug allergy and since all my medications have been long term with no adverse affects. The dermatologist said that the flu vaccine was the cause. The affects lasted over 8 months.
Temp 1-16-02@ 102 degree F, 1-17-02@ 104.5-104.7, 1-18-02 rash saw dr., temp was down, rash on abd, gave Tylenol (day 10), Day 2 gave Motrin
Around 1:30 am my son complained of his eye feeling swollen and tight.  his right eye was completely swollen and closed.  I gave him Benadryl and ibuprofen and water and he went back to bed. Woke up 12 hrs later with a less swollen but still swelled eye and blurred vision. Complained the left side of his face felt numb. Was extremely groggy and tired.
alopecia, complete loss of hair from scalp, chest, armpit, face, eyebrows, nose, ears, groin within 4 to 6 weeks
Initial two days, very sore arm and slight headache.  Sort arm okay after day three. Day 9, itchy, red, slightly swollen 2x2 inch rash at injection site.
red welts on right side of my face; Itchy; slight swelling; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER2613) via an unspecified route of administration in the right arm on 23Mar2021 (at the age of 47-year-old) at 10:00 as a single dose for COVID-19 immunisation. Medical history included high blood pressure and diabetes. Concomitant medications included Pepcid (MANUFACTURER UNKNOWN), celexa (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNWON). The patient was allergic to codeine (MANUFACTURER UNKNOWN) and stadol (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 08:00, the patient experienced itchy, red welts on the right side of the face and slight swelling. No treatment was taken taken for the reported events. The clinical outcome of the events itchy, red welts on right  side of the face and slight swelling were recovering at the time of report.   No follow-up attempts possible. No further information expected.
vaccine reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (vaccine reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (vaccine reaction). At the time of the report, VACCINATION COMPLICATION (vaccine reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Chills, body aches, fever, nausea, vomiting, drop in milk supply.
pt recv vax & devel fever  103.9 R came down to 100.2 R p/tx;vomited x1;dx viral synd poss adverse rxn to immun;
A few minutes after vaccine patient stated he felt warm, we were outside and it was hot. I was contacted by another Dept of health employee about 6:15p stating patient was feeling dizzy and stated that he had the same vaccine 3 weeks ago. Patient never mentioned to me having the vaccine 3 weeks prior, when I questioned him he stated that he did tell the support staff taking his paperwork. Nurse was never notified of this. 6:19pm I took his BP (113/79 HR 87) Patient refused that 911 be called because he felt it was because he had not eaten all day. I had patient eat and he began feeling better.
Was very tired, within a few hours, by evening was extremely cold and shaking uncontrollaby,  Did not have measurable fever and room temperature was 78, but could not get warm for many hours and could not stop shaking violently. Following day did not feel well, and on second night woke up sweating  excessively,  Needed to change clothes and bedding.  Third day developed fever blisters.
CAN'T SWALLOW. FLUSHING. REDNESS AND SWELLING ON FACE. COUGHING. CAN'T BREATHE.
Nurse gave 5-11 BIV as primary series as current recommendation state 5-11 BIV for booster dose only. Patient observed for 15 min post exposure. Discharged WNL.
Headache, Arthralgia, Fever, NauseaVomiting, chills, fatigue Narrative:
Initial misuse report received from a healthcare professional on 14 February 2014. A 5-month-old patient received PENTACEL on an unspecified date. It was reported there the patient had received the ACTHIB and used sterile water to reconstitute and given to a 5 month as the second dose in the series. No adverse event was reported. List of documents held by sender: none.
pt recv vax 29APR99 & had raised red area size of dime @ vax site;c/o itching @ site;no SOB, no rash;
p/vax had T101;rash;advised to observe & bring in if rash is not resolved in 4 days;
Left arm was still bruised a week later. On the 24th I had signs of Vertigo. Which on the 29th it became hard to handle.
I have had a constant headache for over 2 weeks since receiving the shot. It has not gone away.   The headache is what I would call low grade. It's not a pounding pain, but a constant ache.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories. From 19-MAR-2017 through 27-MAR-2017, the patients were vaccinated with improperly stored doses of VAQTA (lot # M036458 with expiration date of 02-MAR-2018; strength, dose, route and anatomical location were not provided), for prophylaxis. It was also reported that the administered doses experienced a temperature excursion during 7 hours at a temperature from 47 degrees Fahrenheit to 77 degrees Fahrenheit on unspecified date. No previous temperature excursion was reported. In addition, a data logger issue was involved. No adverse effects and no product quality complaint were reported. Additional information has been requested. Sender's Comments: US-009507513-1703USA013210: US-009507513-1703USA014483: US-009507513-1703USA014484: US-009507513-1703USA014486.
Initial first few days normal symptoms (aches, fever, headache), few days later followed by sore throat, sinus infection, and bronchitis
itch in both hands/ itchiness in right armpit; Palms of hands are reddened; redness in right armpit; Had heat, swelling and a little soreness at injection site; Had heat, swelling and a little soreness at injection site; Had heat, swelling and a little soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Had heat, swelling and a little soreness at injection site), PRURITUS (itch in both hands/ itchiness in right armpit), PALMAR ERYTHEMA (Palms of hands are reddened), ERYTHEMA (redness in right armpit) and VACCINATION SITE PAIN (Had heat, swelling and a little soreness at injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Prostate cancer (prostate CA) and Lymphoma. Concurrent medical conditions included Sulfonamide allergy (sulfa drugs), Coronary artery disease, Hypercholesterolaemia (High cholesterol controlled) and Hypertension (High blood pressure).   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Had heat, swelling and a little soreness at injection site), VACCINATION SITE PAIN (Had heat, swelling and a little soreness at injection site) and VACCINATION SITE SWELLING (Had heat, swelling and a little soreness at injection site). On 30-Mar-2021, the patient experienced PRURITUS (itch in both hands/ itchiness in right armpit), PALMAR ERYTHEMA (Palms of hands are reddened) and ERYTHEMA (redness in right armpit). At the time of the report, VACCINATION SITE WARMTH (Had heat, swelling and a little soreness at injection site), PRURITUS (itch in both hands/ itchiness in right armpit), PALMAR ERYTHEMA (Palms of hands are reddened), ERYTHEMA (redness in right armpit), VACCINATION SITE PAIN (Had heat, swelling and a little soreness at injection site) and VACCINATION SITE SWELLING (Had heat, swelling and a little soreness at injection site) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No  concomitant medications were reported.   Treatment information was not provided.   This case was linked to MOD-2021-062685 (Patient Link).
Administration of expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine). On 07-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Original expiration was 2Mar2021 states the expiration was changed to 2Oct2021. Nurse states she wrote expired on the box but the doses were accidentally administered.  No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD-2021-345445, MOD-2021-345448, MOD-2021-345472, MOD-2021-345642, MOD-2021-345457, MOD-2021-345456, MOD-2021-345619 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: significant follow up appended : Reporter / Lot no / Expiration Date Updated .
Approximately three hours after vaccination, the mother noted tha the infant had developed a petechial rash on his legs bilaterally.
Patient stated her arm was red, swollen, and hard at injection site starting a day after vaccine. Redness progressed to her leg as well over the course of 2 days and was very sore. Patient started steroid to treat allergic reaction.
This is a spontaneous report from a contactable consumer (patient). A 39-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0158), at the age of 39, via an unspecified route of administration, left arm, on Apr 13, 2021, at 10:30, single dose, for COVID-19 immunisation. Medical history included hypothyroidism and chronic active Epstein-Barr virus infection. The patient has no known allergies. Concomitant medications included levothyroxine sodium, Wellbutrin XL (bupropion hydrochloride), acyclovir sodium and multivitamins; all from unknown dates for unspecified indications. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 13, 2021, at 12:15, patient experienced fever (101.3ºF) with full body flush 2 hours post vaccination, which lasted 6 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On Apr 13, 2021, at 12:15, patient underwent lab test and procedure, which included body temperature: 101.3 F. The outcome of the fever (101.3ºF) and full body flush resolved on Apr 13, 2021, at 18:15. No follow-up attempts needed. No further information expected.
PATIENT REPORTED AN ITCHY SORE ON HER RIGHT ARM THAT APPEARED TO BE IRRITATED. PATIENT REPORTED SCRATCHING THE SORE WHICH RESULTED IN AN OPEN WOUND.
4 days after vaccination  Mom noticed mild swelling of left anterior deltoid.  Patient reports some mild pruritus over the area, but no tenderness.  No evidence of cellulitis or abscess.
This is a spontaneous report by a contactable consumer. This female reported on behalf of her currently 4-month-old son that he began on PREVNAR 13 on left thigh for the treatment of pneumococcal infections on 04Nov2010. Relevant medical history included reflux. Relevant concomitant medications included ranitidine 0.9 mg three times a day for reflux and supplements of vitamin A, vitamin C and vitamin D. Vaccines taken within the last four weeks included ROTAVIRUS in 04Nov2010 and other vaccines were HEPATITIS B in Oct2010, and HEPATITIS B in Sep2010. On 04Nov2010 while on PREVNAR 13 he experienced grey blue V shaped mark on the top layer of dermis which was atypical, not spreading and was maintaining state. Relevant lab data was none. At the time of the report it was unknown if he was taking vaccine. At the time of the report he had not recovered from the grey blue V shaped mark. Follow-up attempts completed. No further information expected.